Young Leaders Caucus

Share

Young Leaders Summit participants

About the Young Leaders Caucus

The American Cancer Society Cancer Action Network Young Leaders Caucus is the ideal space for volunteers, aged 18-35, to connect and engage in cancer advocacy throughout the year. The Young Leaders Caucus fosters opportunities to connect young people to the work of ACS CAN and to others with similar interests. We work to elevate the perspectives of young people, including cancer survivors, about childhood and AYA, to inform and influence ACS CAN priorities and considerations.

Join our slack!
Young Leaders Summit participants

Meet the steering committee!

Meet the steering committee! These are the volunteer leaders of the YLC.  Learn more their role in the YLC

Young Leaders Summit participants

Photos

Check out photos from our various events here.

Young Leaders Summit participants

Newsletters

We release quarterly newsletters detailing our activity,  upcoming events, and any timely announcements.

Young Leaders Summit participants

Calendar

Find out what is happening next with ACS CAN and the YLC.

Young Leaders Summit participants sitting at a table

Resources 

Find all the resources you need to get more engaged with the YLC.

Young Leaders Summit participants working at breakout tables

Working Groups

Find a list of our working groups and their ongoing projects here.

Latest Updates

See More Updates

U.S. Senate Confirms Dr. Marty Makary as FDA Commissioner

March 26, 2025
National

Yesterday, the U.S. Senate voted to confirm Dr. Marty Makary as the next commissioner of the Food and Drug Administration (FDA).

U.S. Senate Confirms Jay Bhattacharya as Director of the National Institutes of Health

March 26, 2025
National

Yesterday, the U.S. Senate voted to confirm Jay Bhattacharya, MD, PhD, as the new director of the National Institutes of Health (NIH).

U.S. House Misses Critical Opportunity to Boost Cancer Research and Prevention Funding; Future Progress in Jeopardy

March 11, 2025
National

Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds.

ACS CAN Calls on Congress to Reject Cuts; Draft Full Appropriations Bills That Include Increases to Protect Cancer Patients

March 10, 2025
National

“With over 2 million people in America expected to be diagnosed with cancer in 2025, now is not the time to halt investments in cancer research, prevention and early detection programs.